General News

General News | Dec. 15, 2014

Government Spending Bill Includes Funding for Vital Lupus Programs

Statement from Sandra C. Raymond, President and CEO of the Lupus Foundation of America

General News | Nov. 18, 2014

Three Lupus Investigators Recognized for Valuable Contributions in Research and Treatment

Lupus Foundation of America presents prestigious career awards during American College of Rheumatology Annual Scientific Meeting

General News | Nov. 15, 2014

Lupus Research Studies Widen Understanding

Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.

General News | Oct. 29, 2014

U.S. Department of Defense Announces $3.4 Million to Support Lupus Research

Award is the largest amount allocated to lupus since 2006

General News | Oct. 09, 2014

New York City Lights Up for Lupus Awareness

Empire State Building Glows Purple to Celebrate Lupus Foundation of America’s National Gala and to Call Attention to Need for Increased Awareness and Investment in Lupus Research

General News | Oct. 02, 2014

Foundation Responds to Eli Lilly and Company’s Release of Data from Clinical Trial of Tabalumab

Sandra C. Raymond, President & CEO of the Lupus Foundation of America, issued the following statement in response to Eli Lilly and Company’s announcement of the results of two Phase III clinical trials of tabalumab.

General News | Sep. 30, 2014

Foundation Announces Pediatric Lupus Research Grantee & LIFELINE Grant Program™ Recipients

The Lupus Foundation of America announced four grants that will allow lupus investigators to continue critical lupus research. Another grant will be used to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis.

General News | Sep. 24, 2014

Foundation Welcomes NIH’s Accelerating Medicines Partnership in Lupus and RA Grantees

The Lupus Foundation of America congratulates and welcomes the first 11 new research groups that have been awarded grants as part of the Accelerating Medicines Partnership in Lupus and Rheumatoid Arthritis (AMP Lupus and RA) Network.